ReviewTranslational oncology2026

NPM1c⁺-driven lncRNA dysregulation in AML: Mechanisms, Controversies and translational roadblocks.

Qiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.